Neither the Tanzanian study nor ours measured total IgA; therefore we are unable to determine if the difference in comparison with the same Boston controls was due to an underlying IgA deficiency in our Pakistani cohort. This evidence concerns the gene CD79A and selective IgA deficiency disease.